Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bruker Announces Acquisition of Prairie Technologies

Published: Friday, September 13, 2013
Last Updated: Thursday, September 12, 2013
Bookmark and Share
Acquisition strengthens Bruker Nano Surfaces Division's position in life science markets.

Bruker Corporation has announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products.

The acquisition strengthens Bruker's position in life science markets, adding to the Bruker Nano Surfaces Division's existing life science atomic force microscopy (Bio-AFM) systems.

Headquartered near Madison, Wisconsin, privately-held Prairie pioneered the use of multiphoton fluorescence microscopy. Its industry-leading multiphoton product offerings have enabled researchers to make revolutionary discoveries in neurobiology and cell biology.

Prairie's products serve an addressable market that is estimated to be more than $150 million annually. The addition of Prairie will enable Bruker to enter the fluorescence microscopy market, which consists of multipoint scanning confocal, single-photon confocal, and multiphoton products.

Prairie has approximately 30 employees globally, and generated revenues of approximately $11 million in 2012. Bruker intends to operate Prairie Technologies as a business unit in the Madison, Wisconsin area, and plans to leverage the global marketing, distribution and service capabilities of the Bruker Nano Surfaces division.

"Prairie Technologies led the way in developing the multiphoton fluorescence microscopy field. Their products and innovations are impressive and have created an enthusiastic following of customers who have used their instruments to achieve groundbreaking results," said Mark R. Munch, Ph.D., President of the Bruker MAT Group.

Munch continued, "Their Ultima two-photon microscopy product line and the new Opterra swept field multipoint scanning confocal fluorescence product line present new exciting areas of growth for Bruker, while providing significant synergies with our Bio-AFM offerings."

"For over seventeen years, Prairie Technologies has been committed to providing leading optical instrument designs and rich software features to researchers in neurobiology and cell biology," remarked Mike Szulczewski, Founder and President of Prairie Technologies, Inc.

Szulczewski continued, "We are extremely pleased to join Bruker, and look forward to continued innovation in the Bruker environment, as well as to enhanced global distribution and service capabilities for our customers."

Scientists conducting uncaging experiments, optogenetics, simultaneous electrophysiology studies, as well as photoactivation, photostimulation and photoablation experiments use Prairie Technologies' systems.

The suite of product solutions for neurobiologists and cell biologists include the Ultima and Ultima In-Vivo two-photon microscopy product lines.

These platforms and the many associated accessories and flexible configurations enable advanced brain slice and intra-vital studies deep into tissues to over 900 microns in penetration depth.

In addition, the new Opterra swept field multipoint scanning confocal fluorescence microscope enables high-speed, live cell imaging and unsurpassed dynamic observation of fast cellular events.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bruker Opens New Preclinical Imaging Center of Excellence for the Americas
Massachusetts Center will provide advanced development, demonstration and customer support capabilities for Bracer’s unique multimodal preclinical imaging systems portfolio.
Thursday, January 30, 2014
Bruker and ImaBiotech Announces Collaboration
Bruker to distribute ImaBiotech's Quantinetix software for quantitative MALDI imaging.
Friday, June 21, 2013
Bruker to Acquire Carestream’s Preclinical In-vivo Imaging Business
Transaction positions in-vivo products for long-term growth.
Monday, September 24, 2012
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Substance Can Potentially Postpone Aging
Researchers bridge the gap between two main aging theories - repairs to the DNA and poor functioning mitochondria.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos